USRE30739EExpiredUtility

Anorexic chromans

Priority: Jul 30, 1974Filed: May 14, 1979Granted: Sep 8, 1981
Est. expiryJul 30, 1994(expired)· nominal 20-yr term from priority
C07D 311/58C07C 37/055C07C 45/673C07C 2602/10
23
PatentIndex Score
2
Cited by
1
References
8
Claims

Abstract

Compounds within formula ##STR1## and their salts wherein X is alkylene of 2-4 carbon atoms; R 1 is hydrogen or alkyl of 1-6 carbon atoms; R 2 is hydrogen, alkyl of 1-6 carbon atoms or benzyl, or R 1 and R 2 together with the nitrogen atom to which they are attached form a 5-, 6- or 7-membered saturated ring; R 3 is aryl; R 4 is hydrogen or alkyl of 1-4 carbon atoms; and R 5 is hydrogen or alkyl of 1-4 carbon atoms; have been found to possess mood-modifying and anorexia inducing activity.

Claims

exact text as granted — not AI-modified
We claim: 
     
       1. A compound of the formula: ##STR32## or a pharmaceutically acceptable acid addition salt thereof wherein X is alkylene of 2-4 carbon atoms; R 1  is hydrogen or alkyl of 1-6 carbon atoms;   R 2  is hydrogen, alkyl of 1-6 carbon atoms or benzyl;   R 3  is 1-naphthyl or 2-naphthyl;   R 4  is hydrogen or alkyl of 1-4 carbon atoms; and   R 5  is hydrogen or alkyl of 1-4 carbon atoms.   
     
     
       2. A compound according to claim 1 wherein NR 1  R 2  is NHCH 3  or N(CH 3 ) 2 . 
     
     
       3. A compound according to claim 1 wherein X is CH 2  CH 2  ; and R 4  and R 5  are methyl. 
     
     
       4. A compound of the formula: ##STR33## or a pharmaceutically acceptable acid addition salt thereof wherein R 10  is hydrogen, methyl or ethyl, R 11  is methyl or ethyl, and   R 12  is 1-naphthyl or 2-naphthyl.   
     
     
       5. A compound according to claim 4 wherein NR 10  R 11  is methylamino or dimethylamino. 
     
     
       6. A compound according to claim 4 wherein R 12  is 2-naphthyl. 
     
     
       7. The compound 2,2-dimethyl-7-methylaminoethoxy-4-(2-naphthyl)chroman or a pharmaceutically acceptable acid addition salt thereof. 
     
     
       8. The compound 2,2-dimethyl-7-dimethylaminoethoxy-4-(2-naphthyl)chroman or a pharmaceutically acceptable acid addition salt thereof.

Join the waitlist — get patent alerts

Track USRE30739E — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.